|
業務類別
|
Health Information Services |
|
業務概覽
|
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States. |
| 公司地址
| 1540 Broadway, 24th Floor, New York, NY, USA, 10036 |
| 電話號碼
| +1 212 295-5800 |
| 傳真號碼
| +1 212 295-5801 |
| 公司網頁
| https://www.schrodinger.com |
| 員工數量
| 850 |
| Dr. Ramy Farid, PhD |
Director, Chief Executive Officer and President |
美元 730.00K |
28/04/2026 |
| Dr. Robert Abel, PhD |
Executive Vice President, Chief Computational Scientist |
-- |
28/04/2026 |
| Dr. Karen Akinsanya, PhD |
President, R&D Therapeutics |
美元 600.00K |
28/04/2026 |
| Mr. Kenneth Patrick Lorton |
Chief Operating Officer, Software, Executive Vice President and Chief Technology Officer |
-- |
28/04/2026 |
| Ms. Yvonne Tran |
Executive Vice President, Chief Legal Officer and Chief People Officer |
美元 584.00K |
28/04/2026 |
| Mr. Richie Jain |
Executive Vice President, Chief Financial Officer and Treasurer |
美元 503.75K |
28/04/2026 |
| Ms. Therese Abrams |
Principal Accounting Officer, Vice President and Corporate Controller |
-- |
12/03/2026 |
| Mr. Paul Davie |
Interim Chief Commercial Officer and Global Head, Software Sales and Marketing |
-- |
20/05/2026 |
|
|
| Mr. Arun Oberoi |
Independent Director |
28/04/2026 |
| Mr. Gary L. Ginsberg |
Independent Director |
28/04/2026 |
| Mr. Gary L. Sender |
Independent Director |
28/04/2026 |
| Mr. Michael M. Lynton |
Chairman of the Board |
28/04/2026 |
| Ms. Bridget A. van Kralingen |
Director |
28/04/2026 |
| Dr. Jeffrey A. Chodakewitz, M.D. |
Independent Director |
28/04/2026 |
| Dr. Ramy Farid, PhD |
Director, Chief Executive Officer and President |
28/04/2026 |
| Dr. Richard A. Friesner, PhD |
Director |
28/04/2026 |
| Dr. Rosana Kapeller-Libermann, M.D.,PhD |
Independent Director |
28/04/2026 |
| Ms. Nancy A. Thornberry |
Independent Director |
28/04/2026 |
|
|
|
|
